Aperio Technologies

What Aperio Technologies does

Aperio Technologies provides digital pathology imaging systems and workflow software for hospitals, reference laboratories, and pharmaceutical and research institutions. Its core product set is organized around three modules: Scan, comprising whole-slide imaging scanners including the high-throughput Aperio GT Elite and the Aperio AT2; Manage, providing secure and scalable image management and integration software with flexible deployment options; and Analyze, offering computational and AI-enabled image analysis tools for cancer diagnostics and pathological review. The company was founded in 1999 in Vista, California, and historically raised approximately $61.6 million across six venture rounds between 2002 and 2012 before being acquired by Leica Biosystems, where it now operates as a product line. The legal operating entity is Leica Biosystems Nussloch GmbH, headquartered in Nussloch, Germany, with North American business operations at 21440 W. Lake Cook Road, Deer Park, Illinois, and the company is ultimately a subsidiary of Danaher Corporation (NYSE: DHR).

Aperio generates revenue through two streams: hardware sales of whole-slide scanners, and software licenses and subscriptions covering image management, integration, and AI-enabled analysis, sold alongside hardware or as standalone licenses. Pricing is not publicly disclosed and is handled through a consultative enterprise sales motion with quote-based engagement. Marketing is multi-channel, combining educational content through the Knowledge Pathway platform, organic social, webinars, and an email newsletter, while distribution leverages Leica Biosystems' global enterprise field sales and an e-commerce storefront for consumables and IHC primary antibodies. Customer segments center on healthcare providers and pathology laboratories (primary) and life sciences researchers (secondary), with "thousands of implementations worldwide" cited by the company. Strategic innovation partnerships with Abcam, Advanced Cell Diagnostics, Cell Signaling Technology, and Molecular Instruments extend the platform into complementary reagent and molecular assay workflows.

Name

Aperio Technologies

Legal name

Leica Biosystems Nussloch GmbH

Website

https://aperio.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

Aperio Technologies, now a digital pathology product line within Leica Biosystems (Danaher Corporation), provides whole-slide imaging scanners, image management software, and AI-enabled analysis tools for hospitals, reference labs, and life sciences research institutions.

Ownership category

akta.pro rank

Product category

Digital Pathology Imaging Systems

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391)

SIC

Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Anatomic Pathology LIS & Digital Pathology Workflow (HLACAMAB)

akta.pro secondary industries

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Medical Imaging AI (HDAAAEAH), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)

Keywords

• Digital pathology imaging
• Whole slide scanning
• Pathology image management
• AI image analysis
• Cancer diagnostics

Headquarters

HQ city

Vista

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Digital Pathology Imaging Systems: Sale of hardware slide scanners (Aperio GT Elite and other models) for whole-slide imaging in pathology labs
2. Software Licenses and Subscriptions: Software solutions for image management, integration, and AI-powered image analysis sold alongside hardware or as separate licenses

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Aperio Technologies sells whole-slide digital pathology imaging scanners, image management and integration software, and AI-enabled image analysis tools. Its Scan, Manage, and Analyze product lines digitize tissue specimens and enable quantitative, computer-vision-based assessment of pathology images for hospitals, reference laboratories, pharmaceutical companies, and research institutions.

Product overview

Aperio Technologies, now part of Leica Biosystems (a Danaher company), offers a modular digital pathology platform comprising slide scanners (Scan), image management software (Manage), and image analysis solutions (Analyze). The product portfolio centers on the Aperio line of whole slide imaging systems designed for cancer diagnostics and pathological review. The platform supports workflows from translational research to routine clinical diagnostics and AI development, with thousands of implementations worldwide. The Leeds Guide documentation provides implementation guidance for organizations transitioning to digital pathology.

Differentiator

Problem solved

Functional benefit

Brands

• Aperio GT Elite Scanner: High-performance digital pathology slide scanner for clinical and research applications
• Aperio AT2
• Aperio Scan
• Aperio Manage
• Aperio Analyze

Products and services

• Aperio GT Elite Scanner High-performance whole-slide imaging scanner designed for high-throughput laboratory environments with advanced imaging capabilities for digital pathology, serving clinical diagnostics and AI development applications.
• Aperio Digital Pathology Slide Scanners (Scan) High-resolution whole-slide imaging scanners that digitize tissue specimens for digital pathology workflows across translational research, routine diagnostics, and AI development use cases.
• Aperio Digital Pathology Software (Manage) Image management and integration software providing secure, scalable solutions with flexible deployment options and automated system communication for digital pathology image access and workflow.
• Aperio Digital Pathology Image Analysis (Analyze) Computational analysis tools for whole-slide images that enable quantitative assessment and AI-powered analysis of digitized tissue specimens, supporting cancer diagnostics and pathology workflows.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• 3DHistech:
• Hamamatsu Photonics: Hamamatsu's NanoZoomer line is one of the most widely deployed whole-slide imaging scanners globally, directly competing with Aperio Scan for clinical and research pathology installations.

Broad incumbents

• Philips (Digital Pathology / IntelliSite): Philips offers IntelliSite digital pathology solutions including whole-slide scanners and pathology workflow software, competing head-on with Aperio in hospital and reference lab channels as part of its broader health technology portfolio.
• Roche (Ventana Digital Pathology): Roche's Ventana DP 200 scanner and companion diagnostic ecosystem compete directly with Aperio, particularly given Roche's strong position in IHC/ISH staining workflows analogous to Leica's.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/AperioDP
• YouTubeyoutube.com/user/LeicaBiosystems
• Facebookfacebook.com/leicabiosystems
• LinkedInlinkedin.com/company/aperio

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds6 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aperio Technologies